Julia Tchou

Professor and Section Chief of Breast Surgery @pennsurgery, working to improve cancer treatment with combination immunotherapy & chemotherapy-free approaches

[VJ Oncology @VJOncology]

#SITC22 | @tchou_julia (@pennsurgery) discusses PR after single radiotherapy + pembro in Ct1N0 #TNBC

⭐ Necrosis of tumor tissue suggests PR post-treatment
⭐ 3/10 pts achieved MPR
⭐ Future research inc lymph nodes and breast cancer subtype analysis

@sitcancer #ImmunoOnc #BCSM

[Julia Tchou @tchou_julia]

Inaugural Women in Oncology Event @PennCancer @PennMedicine @pennsurgery yesterday was mentioned in https://t.co/XABuMInsAF. So grateful to work with amazing co-chairs @CharuAggarwalMD, @NehaVapiwala @lynn_schuchter

[Julia Tchou @tchou_julia]

Penn program addresses ‘barriers and bias’ unique to women in oncology Page 3 https://t.co/ipAMaSXmWV

[Julia Tchou @tchou_julia]

Penn program addresses ‘barriers and bias’ unique to women in oncology Page 3 https://t.co/ipAMaSXmWV

[Julia Tchou @tchou_julia]

Congratulations to Maria Pomponio MS1 & 2018 Harrison Scholar @pennsurgery @PennCancer and co-authors on her manuscript that was recently published in Annals of Surgical Oncology!

[Julia Tchou @tchou_julia]

Congratulations to the @dematteo_lab @pennsurgery @PennCancer

[Angie DeMichele, MD, MSCE, FASCO @AngieDemichele]

#PennMedicine, #PennCancer

[Julia Tchou @tchou_julia]

@adwilliams5 Way to go Austin!

[Julia Tchou @tchou_julia]

Amazing event with amazing turnout @PennCancer 1st Women in Oncology (WIO) event. Our @pennsurgery @CBA_98 Dr. Aarons gave tips on clinical leadership roles to an audience of over 150 registered WIO participants.

[Angie DeMichele, MD, MSCE, FASCO @AngieDemichele]

#oncologywomen

[Julia Tchou @tchou_julia]

So honored to have our work @pennsurgery @PennPlasticSurg @PennMedicine @PennCancer featured in #ACSCC19 Daily Highlights.

[PennSurgery @pennsurgery]

Video interview of @tchou_julia for The #ACSCC19 daily highlights newsletter after her presentation of ERAS reducing narcotic requirement and length of stay in patients undergoing mastectomy with implant based reconstruction. https://t.co/zPdxDzJhyc

[Julia Tchou @tchou_julia]

Our @pennsurgery @PennCancer @PennMedicine last presentation “ERAS reduces periop narcotic requirement and length of stay after mastectomy with implant based reconstruction” was well received! Our breast group is honored to be so well represented (4 SF+2-e-posters)! #ACSCC19

[Julia Tchou @tchou_julia]

We are so proud of Cassie Ye Huang MS1 @pennsurgery @PennCancer @PennMedicine for an outstanding presentation “Assessing patients’ knowledge of the impact of obesity on breast cancer risk” in SF307 Breast III #ACSCC19

[Julia Tchou @tchou_julia]

We are so grateful to Cassie Ye Huang MS1 @pennsurgery @PennCancer @PennMedicine for presenting our work “effect of exercise on anti-tumor immunity” #ACSCC19

[Julia Tchou @tchou_julia]

We are so proud of Maria Pomponio MS1 @pennsurgery @PennCancer @PennMedicine presenting our @tchou_julia work “does time to adjuvant chemotherapy affect outcomes in patients with TNBC” #acscc19 sp220 e-posterIV.

[Julia Tchou @tchou_julia]

#ACSCC19

[Julia Tchou @tchou_julia]

@pennsurgery @PennCancer @PennMedicine we are so proud of our breast surgery fellow Susanna Nazarian presenting our @tchou_julia work “the use of MRI may exaggerate clinical stage and indication for neoadjuvant chemotherapy for HER2+ breast cancer” SF122 #cc2019

[Julia Tchou @tchou_julia]

#acscc2019

[Julia Tchou @tchou_julia]

@PennCancer @pennsurgery @PennMedicine so proud of Maria Pomponio MS1 for presenting our @tchou_julia work “Neoadjuvant chemotherapy does not provide benefit in HER2+ breast cancer with low disease burden”. She nailed it! SF122 #Cc2019

[Julia Tchou @tchou_julia]

@PennCancer @pennsurgery @PennMedicine so proud of Maria Pomponio MS1 for presenting our @tchou_julia work “Neoadjuvant chemotherapy does not provide benefit in HER2+ breast cancer with low disease burden”. She nailed it! SF122 #Cc2019

[Julia Tchou @tchou_julia]

@PennCancer @pennsurgery @PennMedicine so proud of Maria Pomponio MS1 for presenting our @tchou_julia work “Neoadjuvant chemotherapy does not provide benefit in HER2+ breast cancer with low disease burden”. She nailed it! SF122 #Cc2019

[Julia Tchou @tchou_julia]

@pennsurgery @PennCancer @PennMedicine we are so proud of our breast surgery fellow Susanna Nazarian presenting our @tchou_julia work “the use of MRI may exaggerate clinical stage and indication for neoadjuvant chemotherapy for HER2+ breast cancer” SF122 #cc2019

[Julia Tchou @tchou_julia]

@pennsurgery @PennCancer @PennMedicine The Breast Cancer Clinical Program being honored at Philly Fights Cancer Round 5. @tchou_julia So grateful and honored to be part of this amazing team. Over $13 million raised at this wonderful event.

[Julia Tchou @tchou_julia]

@PennCancer Bob Vonderheide and Susan Domchek at @phillyfightscancer with @RealHughJackman to honor the Breast Cancer Clinical Team raising over $13 million to support breast cancer research! Such an honor to be part of the team! @PennMedNews @PennMedicine @pennsurgery

[Julia Tchou @tchou_julia]

@YaleSurgery @theNAMedicine @NitaAhujaMD congratulations!from @pennsurgery @tchou_julia we are so proud of you!!